Chemopreventive effects of fermented brown rice and rice bran against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in female A/J mice

Oncology Reports

Volumn 21, Issue 2, 2009, Pages 321-327

  Phutthaphadoong, Suphot ^a,b   Yamada, Yasuhiro ^a   Hirata, Akihiko ^c   Tomita, Hiroyuki ^a   Taguchi, Ayako ^a   Hara, Akira ^a   Limtrakul, Porn Ngam ^b   Iwasaki, Teruaki ^d   Kobayashi, Hiroshi ^e   Mori, Hideki ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c GIFU UNIVERSITY   (Japan)

^d Genmai Koso Co Ltd   (Japan)

^e Sapporo Cancer Seminar   (Japan)

Author keywords

Fermented brown rice; Lung cancer; Rice bran

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; CYTOCHROME P450 2A5; CYTOCHROME P450 2A6; MESSENGER RNA; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; ANTINEOPLASTIC AGENT; CARCINOGEN; COUMARIN 7 HYDROXYLASE; COUMARIN 7-HYDROXYLASE; NITROSAMINE; UNSPECIFIC MONOOXYGENASE;

A J MOUSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIETARY INTAKE; ENZYME INDUCTION; EXPERIMENTAL DESIGN; FEMALE; LUNG CARCINOGENESIS; LUNG TUMOR; MOUSE; MUTAGENIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RICE BRAN; RISK REDUCTION; TUMOR VOLUME; ANIMAL; ASPERGILLUS ORYZAE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHEMOPROPHYLAXIS; DIETARY FIBER; DRUG EFFECT; FERMENTATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; PHYTOTHERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RICE;

ANIMALS; ANTINEOPLASTIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; ASPERGILLUS ORYZAE; CARCINOGENS; CHEMOPREVENTION; DIETARY FIBER; FEMALE; FERMENTATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; NITROSAMINES; ORYZA SATIVA; PHYTOTHERAPY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 62849106709     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000224     Document Type: Article

References (45)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91: 1194-1210, 1999.
3. Loeb LA, Ernster VL, Warner KE, Abbotts J and Laszlo J: Smoking and lung cancer: an overview. Cancer Res 44: 5940-5958, 1984.
4. Hecht SS: Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11: 559-603, 1998.
5. Akopyan G and Bonavida B: Understanding tobacco smoke carcinogen NNK and lung tumorigenesis. Int J Oncol 29: 745-752, 2006.
6. Wang Y, Zhang Z, Yan Y, Lemon WJ, La Regina M, Morrison C, Lubet R and You M: A chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility. Cancer Res 64: 1647-1654, 2004.
7. Malkinson AM: Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Res 52: S2670-S2676, 1992.
8. Pulling LC, Vuillemenot BR, Hutt JA, Devereux TR and Belinsky SA: Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res 64: 3844-3848, 2004.
9. Isin EM and Guengerich FP: Complex reactions catalyzed by cytochrome P450 enzymes. Biochim Biophys Acta 1770: 314-329, 2007.
10. Jalas JR, Ding X and Murphy SE: Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13. Drug Metab Dispos 31: 1199-1202, 2003.
11. Kamataki T, Fujita K, Nakayama K, Yamazaki Y, Miyamoto M and Ariyoshi N: Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP. Drug Metab Rev 34: 667-676, 2002.
12. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T and Kuroiwa Y: Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24: 1212-1217, 1996.
13. Ariyoshi N, Miyamoto M, Umetsu Y, Kunitoh H, Dosaka-Akita H, Sawamura Y, Yokota J, Nemoto N, Sato K and Kamataki T: Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. Cancer Epidemiol Biomarkers Prev 11: 890-894, 2002.
14. Fujieda M, Yamazaki H, Saito T, Kiyotani K, Gyamfi MA, Sakurai M, Dosaka-Akita H, Sawamura Y, Yokota J, Kunitoh H and Kamataki T: Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis 25: 2451-2458, 2004.
15. Lindberg R, Burkhart B, Ichikawa T and Negishi M: The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene. J Biol Chem 264: 6465-6471, 1989.
16. Taniguchi H, Hosoda A, Tsuno T, Maruta Y and Nomura E: Preparation of ferulic acid and its application for the synthesis of cancer chemopreventive agents. Anticancer Res 19: 3757-3761, 1999.
17. Graf E, Empson KL and Eaton JW: Phytic acid. A natural antioxidant. J Biol Chem 262: 11647-11650, 1987.
18. Xu Z, Hua N and Godber JS: Antioxidant activity of tocopherols, tocotrienols, and gamma-oryzanol components from rice bran against cholesterol oxidation accelerated by 2,2′-azobis(2-methylpropionamidine) dihydrochloride. J Agric Food Chem 49: 2077-2081, 2001.
19. Van Rensburg SJ, Hall JM and Du Bruyn DB: Effects of various dietary staples on esophageal carcinogenesis induced in rats by subcutaneously administered N-nitrosomethylbenzylamine. J Natl Cancer Inst 75: 561-566, 1985.
20. Kawabata K, Yamamoto T, Hara A, Shimizu M, Yamada Y, Matsunaga K, Tanaka T and Mori H: Modifying effects of ferulic acid on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Lett 157: 15-21, 2000.
21. Tanaka T, Kojima T, Kawamori T, Wang A, Suzui M, Okamoto K and Mori H: Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis 14: 1321-1325, 1993.
22. Katyama M, Yoshimi N, Yamada Y, Sakata K, Kuno T, Yoshida K, Qiao Z, Vihn PQ, Iwasaki T, Kobayashi H and Mori H: Preventive effect of fermented brown rice and rice bran against colon carcinogenesis in male F344 rats. Oncol Rep 9: 817-822, 2002.
23. Katayama M, Sugie S, Yoshimi N, Yamada Y, Sakata K, Qiao Z, Iwasaki T, Kobayashi H and Mori H: Preventive effect of fermented brown rice and rice bran on diethylnitrosoamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats. Oncol Rep 10: 875-880, 2003.
24. Tomita H, Kuno T, Yamada Y, Oyama T, Asano N, Miyazaki Y, Baba S, Taguchi A, Hara A, Iwasaki T, Kobayashi H and Mori H: Preventive effect of fermented brown rice and rice bran on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Oncol Rep 19: 11-15, 2008.
25. Kuno T, Hirose Y, Hata K, Kato K, Qiang SH, Kitaori N, Hara A, Iwasaki T, Yoshimura T, Wada K, Kobayashi H and Mori H: Preventive effect of fermented brown rice and rice bran on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats. Int J Oncol 25: 1809-1815, 2004.
26. Kuno T, Hirose Y, Yamada Y, Hata K, Qiang SH, Asano N, Oyama T, Zhi H, Iwasaki T, Kobayashi H and Mori H: Chemoprevention of mouse urinary bladder carcinogenesis by fermented brown rice and rice bran. Oncol Rep 15: 533-538, 2006.
27. Tazawa K, Naoko F and Hirohide N: Superoxide scavenging effect of fermented brown rice determined by ESR spin-trapping method (in Japanese). Food Style 3: 32-37, 1999.
28. Dungworth D, Rittinghansen S, Schwarz L, Harkema J, Hayashi Y and Kittel B: Respiratory system and mesothelium. In: International Classification of Rodent Tumors: The Mouse. Springer, Berlin, pp87-138, 2001.
29. Wiener D, Doerge DR, Fang JL, Upadhyaya P and Lazarus P: Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4. Drug Metab Dispos 32: 72-79, 2004.
30. Tulunay OE, Hecht SS, Carmella SG, Zhang Y, Lemmonds C, Murphy S and Hatsukami DK: Urinary metabolites of a tobacco-specific lung carcinogen in non-smoking hospitality workers. Cancer Epidemiol Biomarkers Prev 14: 1283-1286, 2005.
31. Bacchi CE and Gown AM: Detection of cell proliferation in tissue sections. Braz J Med Biol Res 26: 677-687, 1993.
32. Rindi G, D'Adda T, Froio E, Fellegara G and Bordi C: Prognostic factors in gastrointestinal endocrine tumors. Endocr Pathol 18: 145-149, 2007.
33. Van Diest PJ, van der Wall E and Baak JP: Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol 57: 675-681, 2004.
34. Gatter KC, Dunnill MS, Gerdes J, Stein H and Mason DY: New approach to assessing lung tumours in man. J Clin Pathol 39: 590-593, 1986.
35. Soomro IN and Whimster WF: Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with AgNOR scores. J Pathol 162: 217-222, 1990.
36. D'Ambrosio SM, Gibson-D'Ambrosio RE, Wani G, Casto B, Milo GE, Kelloff GJ and Steele VE: Modulation of Ki67, p53 and RARbeta expression in normal, premalignant and malignant human oral epithelial cells by chemopreventive agents. Anticancer Res 21: 3229-3235, 2001.
37. Ferrandina G, Ranelletti FO, Legge F, Lauriola L, Salutari V, Gessi M, Testa AC, Werner U, Navarra P, Tringali G, Battaglia A and Scambia G: Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study. Clin Cancer Res 9: 4324-4331, 2003.
38. Esaki H, Kawakishi S, Morimitsu Y and Osawa T: New potent antioxidative o-dihydroxyisoflavones in fermented Japanese soybean products. Biosci Biotechnol Biochem 63: 1637-1639, 1999.
39. Hirota A, Taki S, Kawaii S, Yano M and Abe N: 1,1-Diphenyl-2-picrylhydrazyl radical-scavenging compounds from soybean miso and antiproliferative activity of isoflavones from soybean miso toward the cancer cell lines. Biosci Biotechnol Biochem 64: 1038-1040, 2000.
40. Chen YC, Inaba M, Abe N and Hirota A: Antimutagenic activity of 8-hydroxyisoflavones and 6-hydroxydaidzein from soybean miso. Biosci Biotechnol Biochem 67: 903-906, 2003.
41. Ohta T, Nakatsugi S, Watanabe K, Kawamori T, Ishikawa F, Morotomi M, Sugie S, Toda T, Sugimura T and Wakabayashi K: Inhibitory effects of Bifidobacterium-fermented soy milk on 2- amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones. Carcinogenesis 21: 937-941, 2000.
42. Fukutake M, Takahashi M, Ishida K, Kawamura H, Sugimura T and Wakabayashi K: Quantification of genistein and genistin in soybeans and soybean products. Food Chem Toxicol 34: 457-461, 1996.
43. Zhou JR, Yu L, Zhong Y and Blackburn GL: Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr 133: 516-521, 2003.
44. Shimoji Y, Tamura Y, Nakamura Y, Nanda K, Nishidai S, Nishikawa Y, Ishihara N, Uenakai K and Ohigashi H: Isolation and identification of DPPH radical scavenging compounds in Kurosu (Japanese unpolished rice vinegar). J Agric Food Chem 50: 6501-6503, 2002.
45. Hudson EA, Dinh PA, Kokubun T, Simmonds MS and Gescher A: Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol Biomarkers Prev 9: 1163-1170, 2000.